| 241/318 | US=92 / Biol/Mol Larsen AK, Skladanowski A. Established cancer therapies: perturbations of cellular functions by topoisomerase II inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 407-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TOPOISOMERASE II; AGENTES ANTICANCERIGENOS; DOXORRUBICINA; ETOPOSIDE; MORTE CELULAR; PARADA DO CRESCIMENTO; APOPTOSE; NECROSE; CATASTRIOHE MITOTICO; INDUZIDA POR DROGAS PSEUDOSENESCENCE; AUTOFAGIA |
| 242/318 | US=92 / Biol/Mol Klein LE, Horwitz SB. Established cancer therapies: contributions of apoptosis ana senescence to cytotoxicity produced by microtubule-stabilizing agents. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 465-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TAXOL; DISCODERMOLIDE; MICROTUBULOS ACELEROU A SENESCENCIA; AGENTES ESTABILIZADORES MIROTUBULE; APOPTOSE; CATASTROFE MITOTICA |
| 243/318 | US=92 / Biol/Mol Doll JA, Hobbs JE, Soff GA. Recent and developing cancer therapies: role of apoptosis in anti-angiogenic cancer therapies. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 537-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANGIOGENESE; APOPTOSE; THROMBOSPONDIN-1; CELULAS ENDOTELIAIS; ANTI-ANGIOGENICO |
| 244/318 | US=92 / Biol/Mol Oleinick NL, Morris RL, Nieminem AL. Recent and developing cancer therapies: photodynamic therapy-induced apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 557-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA FOTODINAMICA; FOTOSSENSIBILIZADOR; MITOCONDRIA LISOSSOMO; RETICULO ENDOPLASMATICO; APOPTOSE |
| 245/318 | US=92 / Biol/Mol Fulda S, Debatin KM. Recent and developing cancer therapies: modulation of TRAIL signaling for cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 579-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 246/318 | US=95 / Biol/Mol Fang B, Roth JA. Vectors: adenovector-mediated cancer gene therapy. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 3-22. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; VETORES; ADENOVETOR MEDIADA; ADENOVIRUS; VETOR ALVO; APOPTOSE; ENSAIOS CLINICOS |
| 247/318 | US=95 / Biol/Mol Zhang L, Fang B. Gene therapy approaches: oncogenes, tumor suppressor genes and apoptosis-inducing genes utilized in cancer gene therapy. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 173-84. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; TERAPIA DE GENES; ONCOGENES; GENES SUPRESSORES DE TUMORES; APOPTOSE; ADENOVIRUS |
| 248/318 | US=95 / Biol/Mol Chada S, Bocangel D, Pataer A, Mhashilkar AM, Inoue S, Miyahara R, Roth JA, Grimm EA, Swisher SG, Hunt KK, Ramesh R. Clinical applications: MDA-7/IL -24 as a multi-modality therapy for cancer. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 413-33. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; APLICACOES CLINICAS; MDA-7/IL-24; TERAPIA MULTI-MODALIDADE; APOPTOSE; CITOCINA; ANTIANGIOGENESE |
| 249/318 | US=10 / Biol/Mol Pelengaris S, Khan M. Apoptosis. In: ___. The molecular biology of cancer. Oxford: Blackwell, 2006. p. 251-78. ISBN 978-1-4051-1814-9. FORMACAO DE CANCER; APOPTOSE CONTRA NECROSE; SUPRESSOR TUMORAL P53; MORTE CELULAR |
| 250/318 | US=12-C / Biol/Mol Alberts B, Bray D, Hopkin K, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Controle do ciclo celular e morte celular. In: ___. Fundamentos da biologia celular. 2ª ed. Porto Alegre: Artmed, 2006. p. 611-36. ISBN 85-3630679-7. CICLO CELULAR; MORTE CELULAR; CICLINAS; CDKS; MORTE CELULAR PROGRAMADA; APOPTOSE |
| 251/318 | US=17 / Biol/Mol Kiaris H. Basic aspects: the cell's life and death: cell cycle, senescence and apoptosis. In: ___. Understanding carcinogenesis: an introduction to the molecular basis of cancer. Weinheim: Wiley-VCH, 2006. p. 5-13. ISBN 978-3-527-31486-7. CICLO CELULAR; SENESCENCIA; APOPTOSE; MORTE CELULAR; APOPTOSE CONTRA NECROSE |
| 252/318 | US=1 / Fisiologia Guyton AC, Hall JE. Controle genético da síntese de proteínas, função celular e reprodução celular. In: ___. Tratado de fisiologia médica. 11ª ed. Rio de Janeiro: Elsevier, 2006. p. 27-42. ISBN 853521641-7. CODIGO GENETICO; CODIGO DO DNA; SINTESE DE RNA; RNA DE TRANSFERENCIA; RNA RIBOSSOMICO; PROCESSO DE TRADUCAO; PROCESSO DE TRANSCRICAO; REGULACAO GENETICA; REPRODUCAO CELULAR; MITOSE CELULAR; DIFERENCIACAO CELULAR; APOPTOSE; CANCER |
| 253/318 | US=2 / Biol/Mol Gülow K, Kaminski M, Krammer PH. Death receptor: the role of CD95/CD95 ligand signaling in apoptosis and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 3-30. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA CD95; SISTEMA CD95L; SINALIZACAO DA APOPTOSE; CANCER; MAQUINARIA APOPTOTICA; VIA INTRINSECA; VIA EXTRINSECA; MITOCONDRIAS; MECANISMOS DE RESISTENCIA; ANGIOGENESE |
| 254/318 | US=2 / Biol/Mol Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS |
| 255/318 | US=2 / Biol/Mol Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5. RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA |
| 256/318 | US=2 / Biol/Mol Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5. RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE |
| 257/318 | US=2 / Biol/Mol Saelens X, Festjens N, Walle LV, Vandenabeele P. Mitochondria: role of mitochondrial proteins in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 183-221. ISBN 978-3-527-31237-5. APOPTOSE; PAPEL DAS PROTEINAS MITOCONDRIAIS; FAMILIA BCL-2; PERMEABILIZACAO DA MEMBRANA MITOCONDRIAL; MUTACOES APOPTOTICAS; CITOCROMO C |
| 258/318 | US=2 / Biol/Mol Vahsen N, Kroemer G. Mitochondria: apoptosis-inducing factor. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 233-55. ISBN 978-3-527-31237-5. |
| 259/318 | US=2 / Biol/Mol Adrain C, Martin SJ. Effector systems: caspases: agents of defense and destruction. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 259-81. ISBN 978-3-527-31237-5. |
| 260/318 | US=2 / Biol/Mol Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5. FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE |